Full Phase II Data Reinforces Crinecerfont As A Serious Opportunity For Neurocrine BiosciencesSeeking Alpha • 06/09/20
Neurocrine Biosciences Reports Positive Phase II Data for Crinecerfont in Adults with Congenital Adrenal Hyperplasia at ENDO Online 2020PRNewsWire • 06/08/20
Here's The Next Catalyst For Buy Zone-Lingering Neurocrine BiosciencesInvestors Business Daily • 06/04/20
Neurocrine Biosciences to Present at the Jefferies Virtual Healthcare ConferencePRNewsWire • 05/26/20
Teladoc, Bristol Myers, Quidel, Neurocrine Bio, Tandem Diabetes: 5 Health Stocks To Monitor CloselyInvestors Business Daily • 05/23/20
Neurocrine Biosciences to Present at the RBC Capital Markets 2020 Global Healthcare ConferencePRNewsWire • 05/14/20
Neurocrine Bioscineces' (NBIX) CEO Kevin Gorman on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/07/20
Neurocrine Biosciences (NBIX) Q1 Earnings and Revenues Top EstimatesZacks Investment Research • 05/06/20
Is a Surprise Coming for Neurocrine Biosciences (NBIX) This Earnings Season?Zacks Investment Research • 05/05/20
Stock Upgrades: Neurocrine Biosciences Shows Rising Relative StrengthInvestors Business Daily • 03/11/20
Neurocrine Biosciences Earns Membership In 95-Plus Composite Rating ClubInvestors Business Daily • 02/19/20
Neurocrine Biosciences, Inc. (NBIX) CEO Kevin Gorman on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 02/05/20